Urologix Inc
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides P… Read more
Urologix Inc (ULGX) - Total Liabilities
Latest total liabilities as of March 2015: $13.09 Million USD
Based on the latest financial reports, Urologix Inc (ULGX) has total liabilities worth $13.09 Million USD as of March 2015.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Urologix Inc - Total Liabilities Trend (1995–2014)
This chart illustrates how Urologix Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Urologix Inc Competitors by Total Liabilities
The table below lists competitors of Urologix Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
For The Earth Corp
PINK:FTEG
|
USA | $13.83 Million |
|
Great American Financial Corporation
PINK:GAFL
|
USA | $2.38 Million |
|
Patient Portal Technologies Inc
PINK:PPRG
|
USA | $5.65 Million |
|
Velocity Energy Inc
PINK:VCYE
|
USA | $14.11 Million |
|
Interplay Entertainment Corp
PINK:IPLY
|
USA | $3.42 Million |
|
MabCure Inc
PINK:MBCI
|
USA | $935.15K |
|
Pacific Conquest Holdings Inc
PINK:PCHK
|
USA | $31.66K |
|
Andatee China Marine Fuel Services
PINK:AMCF
|
USA | $197.56 Million |
Liability Composition Analysis (1995–2014)
This chart breaks down Urologix Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Urologix Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Urologix Inc (1995–2014)
The table below shows the annual total liabilities of Urologix Inc from 1995 to 2014.
| Year | Total Liabilities | Change |
|---|---|---|
| 2014-06-30 | $12.64 Million | +4.44% |
| 2013-06-30 | $12.11 Million | +0.47% |
| 2012-06-30 | $12.05 Million | +528.59% |
| 2011-06-30 | $1.92 Million | -4.01% |
| 2010-06-30 | $2.00 Million | -9.88% |
| 2009-06-30 | $2.22 Million | -39.00% |
| 2008-06-30 | $3.63 Million | -23.96% |
| 2007-06-30 | $4.78 Million | +21.95% |
| 2006-06-30 | $3.92 Million | -34.27% |
| 2005-06-30 | $5.96 Million | +9.30% |
| 2004-06-30 | $5.45 Million | -19.28% |
| 2003-06-30 | $6.76 Million | -9.79% |
| 2002-06-30 | $7.49 Million | +1.89% |
| 2001-06-30 | $7.35 Million | +130.77% |
| 2000-06-30 | $3.19 Million | -8.99% |
| 1999-06-30 | $3.50 Million | -16.67% |
| 1998-06-30 | $4.20 Million | +31.25% |
| 1997-06-30 | $3.20 Million | +77.78% |
| 1996-06-30 | $1.80 Million | +100.00% |
| 1995-06-30 | $900.00K | -- |